Regulation of Cyclin A-Cdk2 by SCF Component Skp1 and F-Box Protein Skp2

REFERENCES

• Aprelikova, O., Y. Xiong, and J. Liu 1995. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270:18195–18197.
   PubMed Web of Science ®Google Scholar
• Ausubel F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, K. Struhl 1991. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
   Google Scholar
• Bai, C., R. Richman, and J. Elledge 1994. Human cyclin F. EMBO J. 13:6087–6098.
   PubMed Web of Science ®Google Scholar
• Bai, C., P. Sen, K. Hofmann, L. Ma, M. Goebl, J. W. Harper, and J. Elledge 1996. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86:263–274.
   PubMed Web of Science ®Google Scholar
• Chao, Y., Y.-L. Shih, J.-H. Chiu, G.-Y. Chau, W. Y. Lui, W. K. Yang, S.-D. Lee, and J. Huang 1998. Overexpression of cyclin A but not Skp2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58:985–990.
   PubMed Web of Science ®Google Scholar
• Connelly, C., and J. Hieter 1996. Budding yeast SKP1 encodes an evolutionarily conserved kinetochore protein required for cell cycle progression. Cell 86:275–285.
   PubMed Web of Science ®Google Scholar
• Demetrick, D. J., H. Zhang, and J. Beach 1996. Chromosomal mapping of the genes for the human CDK2/cyclin A-associated proteins p19 (SKP1A and SKP1B) and p45 (SKP2). Cytogenet. Cell Genet. 73:104–107.
   PubMedGoogle Scholar
• Feldman, R. M. R., C. C. Correll, K. B. Kaplan, and J. Deshaies 1997. A complex of cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91:221–230.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and J. Bujard 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and J. Wei 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387–400.
   PubMed Web of Science ®Google Scholar
• Heuvel, S. V. D., and J. Harlow 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
   PubMedGoogle Scholar
• Horton, R. M., L. R. Pease 1991. Recombination and mutagenesis of DNA sequences using PCR, p. 217–247. In M. J. McPherson (ed.), Directed mutagenesis. IRL Press, Oxford, England.
   Google Scholar
• Kamps, M. P. 1991. Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. Methods Enzymol. 201:21–27.
   PubMedGoogle Scholar
• Kobayashi, H., E. Steward, R. Poon, J. P. Adamczewski, J. Gannon, and J. Hunt 1992. Identification of the domains in Xenopus cyclin A required for binding to and activation of p34cdc2 and p32cdk2 protein kinase subunits, and for cell cycle regulated proteolysis. Mol. Biol. Cell 3:1279–1294.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and J. Harlow 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862.
   PubMed Web of Science ®Google Scholar
• Lee, M. H., M. Nikolic, C. A. Baptista, E. Lai, L. H. Tsai, and J. Massague 1996. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93:3259–3263.
   PubMed Web of Science ®Google Scholar
• Lisztwan, J., A. Marti, H. Sutterlüty, M. Gstaiger, C. Wirbelauer, and J. Krek 1998. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17:368–383.
   PubMedGoogle Scholar
• Lu, K. P., and J. Hunter 1995. Evidence for a NIMA-like mitotic pathway in vertebrate cells. Cell 81:413–424.
   PubMed Web of Science ®Google Scholar
• Lyapina, S. A., C. C. Correll, E. T. Kipreos, and J. Deshaies 1998. Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein. Proc. Natl. Acad. Sci. USA 95:7451–7456.
   PubMedGoogle Scholar
• Mathias, N., S. L. Johnson, M. Winey, A. E. Adams, L. Goetsch, J. R. Pringle, B. Byers, and J. Goebl 1996. Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins. Mol. Cell. Biol. 16:6634–6643.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13:261–291.
   PubMed Web of Science ®Google Scholar
• Pines, J., and J. Hunter 1990. Human cyclin A is adenovirus E1A-associated protein p60, and behaves differently from cyclin B. Nature 346:760–763.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y., J. Lew, and J. Hunter 1997. Identification of functional domains in the neuronal Cdk5 activator protein. J. Biol. Chem. 272:5703–5708.
   PubMedGoogle Scholar
• Poon, R. Y. C. 1996. Cell cycle control, p. 246–255. In J. R. Bertino (ed.), Encyclopedia of cancer. Academic Press, San Diego, Calif.
   Google Scholar
• Poon, R. Y. C., M. S. Chau, K. Yamashita, and J. Hunter 1997. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:5168–5178.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y. C., and J. Hunter 1995. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science 270:90–93.
   PubMedGoogle Scholar
• Poon, R. Y. C., W. Jiang, H. Toyoshima, and J. Hunter 1996. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr14/Tyr15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271:13283–13291.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y. C., H. Toyoshima, and J. Hunter 1995. Redistribution of the CDK inhibitor p27 between different cyclin · CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or UV irradiation. Mol. Biol. Cell 6:1197–1213.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y. C., K. Yamashita, J. P. Adamczewski, T. Hunt, and J. Shuttleworth 1993. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J. 12:3123–3132.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y. C., K. Yamashita, M. Howell, M. A. Ershler, A. Belyavsky, and J. Hunt 1994. Cell cycle regulation of the p34cdc2/p33cdk2-activating kinase p40MO15. J. Cell Sci. 107:2789–2799.
   PubMedGoogle Scholar
• Schwob, E., T. Böhm, M. D. Mendenhall, and J. Nasmyth 1994. The B-type cyclin kinase inhibitor p40SIC1 controls the G1/S transition in Saccharomyces cerevisiae. Cell 79:233–244.
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and J. Clurman 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464–1478.
   PubMed Web of Science ®Google Scholar
• Skowyra, D., K. L. Craig, M. Tyers, S. J. Elledge, and J. Harper 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91:209–219.
   PubMed Web of Science ®Google Scholar
• Stepanova, L., X. Leng, S. B. Parker, and J. Harper 1996. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10:1491–1502.
   PubMed Web of Science ®Google Scholar
• van der Geer, P., K. Luo, B. M. Sefton, T. Hunter 1994. Phosphopeptide mapping and phosphoamino acid analysis on cellulose thin-layer plates, p. 422–450. In J. E. Celis (ed.), Cell biology: a laboratory handbook. Academic Press, San Diego, Calif.
   Google Scholar
• Willems, A. R., S. Lanker, E. E. Patton, K. L. Craig, T. F. Nason, N. Mathias, R. Kobayashi, C. Wittenberg, and J. Tyers 1996. Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell 86:453–463.
   PubMed Web of Science ®Google Scholar
• Woo, M. S., I. Sanchez, and J. Dynlacht 1997. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 17:3566–3579.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., H. Zhang, and J. Beach 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572–1583.
   PubMed Web of Science ®Google Scholar
• Zhang, H., G. J. Hannon, and J. Beach 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750–1758.
   PubMed Web of Science ®Google Scholar
• Zhang, H., R. Kobayashi, K. Galaktionov, and J. Beach 1995. p19Skp1 and p45Skp2 are essential elements of the cyclin A/CDK2 S-phase kinase. Cell 82:915–925.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Y. Xiong, and J. Beach 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897–906.
   PubMed Web of Science ®Google Scholar